UMIN ID: UMIN000008113
Registered date:06/06/2012
A multi-center, prospective study of Zimmer Natural Nail System GT Femoral Nails
Basic Information
| Recruitment status | Complete: follow-up complete |
|---|---|
| Health condition(s) or Problem(s) studied | Primary femoral shaft fractures (AO 32-A1 to 32-C3) |
| Date of first enrollment | 2012/06/01 |
| Target sample size | 100 |
| Countries of recruitment | Japan |
| Study type | Observational |
| Intervention(s) |
Outcome(s)
| Primary Outcome | CT Assessments |
|---|---|
| Secondary Outcome | Radiographic Assessment, Clinical Assessments and Safety Assessment |
Key inclusion & exclusion criteria
| Age minimum | 18years-old |
|---|---|
| Age maximum | 75years-old |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | 1).Patient with obliteration of medullary canal due to a previous fracture or tumor 2).Patient with excessive bow or deformity at bone shaft 3).Patient with insufficient bone substance or bone quality 4).Patient with all concomitant diseases that can impair the functioning and the success of the implant 5).Patient with infection 6).Patient with insufficient blood circulation 7).Patient is skeletally immature 8).Patient who is suspected to have a metal allergy 9).Patient who is pregnant, suspected pregnancy or plan to get pregnant during the study observation period 10).Patient with pathologic fracture (including fracture caused by long-term treatment of Bisphosphonate) 11).Patient with periprosthetic fracture 12).Patient with history of deep vein thrombosis (DVT) or pulmonary embolism (PE) 13).Patient who is under medication for Diabetes mellitus (DM) or with suspected DM, and whose HbA1c NGSP (National Glycohemoglobin Standardization Program) is equal or over than 6.5 % or JDS(Japan Diabetes Society) is equal or over than 6.1% 14).Patient with osseous metabolic diseases (excluding osteoporosis) 15).Patient with bilateral fracture or history of fracture at the other side on femur 16).Patient with any comorbidity (e.g. dementia, schizophrenia, depression, panic disorder or generalized anxiety disorder) which may affect the ability of informed consent or completion of assessments 17).Patient who will have to undergo THA, TKA or any operation of lower extremities within 6 months after enrollment 18).Patient who underwent THA, TKA or any operation of lower extremities within 6 months before enrollment |
Related Information
| Primary Sponsor | Zimmer K.K. |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | Zimmer Biomet G.K. |
| Secondary ID(s) |
Contact
| public contact | |
| Name | Akira Kashima |
| Address | 2-11-1 Shibakoen, Minato-ku, Tokyo, Japan Japan |
| Telephone | 03-6402-6773 |
| akira.kashima@zimmerbiomet.com | |
| Affiliation | Zimmer Biomet G.K. Clinical Affairs |
| scientific contact | |
| Name | Hiroshi Nagano |
| Address | 2-1-2 Asahicho, Takamatsu, Kagawa 760-8557, Japan Japan |
| Telephone | 087-811-3333 |
| chuobyoin@pref.kagawa.lg.jp | |
| Affiliation | Kagawa Prefectural Central Hospital Orthopaedic Surgery |